Refine Search

New Search

Results: 6

(searched for: doi:10.3410/m4-21)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Published: 5 June 2020
by MDPI
Nanomaterials, Volume 10; https://doi.org/10.3390/nano10061120

Abstract:
Pelvic organ prolapse (POP) is a hidden women’s health disorder that impacts 1 in 4 women across all age groups. Surgical intervention has been the only treatment option, often involving non-degradable meshes, with variable results. However, recent reports have highlighted the adverse effects of meshes in the long term, which involve unacceptable rates of erosion, chronic infection and severe pain related to mesh shrinkage. Therefore, there is an urgent unmet need to fabricate of new class of biocompatible meshes for the treatment of POP. This review focuses on the causes for the downfall of commercial meshes, and discusses the use of emerging technologies such as electrospinning and 3D printing to design new meshes. Furthermore, we discuss the impact and advantage of nano-/microstructured alternative meshes over commercial meshes with respect to their tissue integration performance. Considering the key challenges of current meshes, we discuss the potential of cell-based tissue engineering strategies to augment the new class of meshes to improve biocompatibility and immunomodulation. Finally, this review highlights the future direction in designing the new class of mesh to overcome the hurdles of foreign body rejection faced by the traditional meshes, in order to have safe and effective treatment for women in the long term.
, Michał Ciebiera, Li-Te Lin, Zaki Sleiman, Taís Marques Cerentini, , Ilker Kahramanoglu, Simone Bruni, , Michele Fichera
Published: 1 January 2019
Menopausal Review, Volume 18, pp 184-190; https://doi.org/10.5114/pm.2019.89496

Abstract:
Although female sexual dysfunctions are common among women with urogynecological conditions, they have not been thoroughly studied and there are still many questions without an answer. The recent evidence on sexual disorders in women with urogynecological diseases shows a quite wide spectrum of...
Journal of Psychosomatic Obstetrics & Gynecology, Volume 39, pp 164-166; https://doi.org/10.1080/0167482x.2017.1294155

Abstract:
The aim of this work is to propose a brief comment about the impact of pelvic organ prolapse on the quality of life and the psychological well-being of the affected women.
Clinical Medicine Insights: Urology, Volume 8; https://doi.org/10.4137/CMU.S13181

Abstract:
Urinary incontinence in women is quite prevalent today and management can be costly. Urinary incontinence can be minimal or quite bothersome, limiting activities of daily living. It is subdivided into urgency urinary incontinence, stress urinary incontinence, and mixed urinary incontinence. As such, treatment can vary immensely depending on the clinical presentations, ranging from behavioral modification to medicinal therapies to surgical procedures. First-line management for all urinary incontinence includes lifestyle and behavioral modifications. Historically, treatment options for urgency urinary incontinence were predominantly antimuscarinics, while more recent therapies include oral beta-3 agonist administration, sacral neuromodulation, onabotulinumtoxinA injection, and posterior tibial nerve stimulation. Stress urinary incontinence can be treated with a variety of urethral bulking agent injections or sling-based procedures using mesh, autologous fascia, or cadaveric fascia, as well as urethral intrasphincteric injections of autologous muscle-derived cells in new clinical trials. These recent advances that have been developed to help better curb urinary incontinence are discussed in this review.
Published: 1 January 2013
Ochsner Journal, Volume 13, pp 278-83

Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top